CDK4 and breast carcinoma: To gain more insights into which genes involved in cell cycle regulation may modulate the anti-tumor efficacy of CDK4/6i in breast cancer, we performed CRISPR/Cas9-mediated genetic screen in MCF7 and MDA-MB-231 breast cancer cell lines (Supplementary Fig. 1a, Supplementary Data 1).